Home  /  Conditions  /  Insomnia Neurological Health

Insomnia

Insomnia is not a sleep problem. It is a waking problem expressed at night. Elevated evening cortisol, blood sugar instability, thyroid dysfunction, neurotransmitter depletion, progesterone deficiency, and circadian rhythm disruption each produce distinct insomnia patterns that are identifiable through clinical history and laboratory evaluation. Conventional treatment prescribes sedative medication that forces sleep while the biological mechanism preventing it remains active. Functional medicine identifies why the brain cannot transition to sleep and corrects the specific driver producing the wakefulness.

Neurological HealthRoot-Cause Sleep MedicineMulti-Mechanism Disorder
30 to 40%of adults experience insomnia symptoms, making it the most common sleep complaint
Multi-Drivercortisol, blood sugar, thyroid, GABA, progesterone, and circadian rhythm converge
Correctablewhen the specific biological mechanism preventing sleep is identified and treated
Schedule a Consultation
← Back to Conditions

Condition: Insomnia  |  Category: Neurological Health  |  Reviewed by: Brian Lamkin, DO

What Is Insomnia?

Insomnia is the persistent difficulty initiating sleep, maintaining sleep, or waking too early with inability to return to sleep, despite adequate opportunity and circumstances for sleep, resulting in impaired daytime function. It affects 30 to 40 percent of adults and is the most common sleep complaint worldwide. Chronic insomnia (lasting 3 or more months, 3 or more nights per week) is not merely inconvenient; it independently increases the risk of cardiovascular disease, type 2 diabetes, depression, cognitive decline, immune dysfunction, and all-cause mortality.

Insomnia presents in distinct clinical patterns that correspond to specific biological mechanisms. Sleep-onset insomnia (difficulty falling asleep) is most commonly driven by elevated evening cortisol, GABA deficiency, or circadian rhythm disruption. Sleep-maintenance insomnia (waking in the middle of the night) is most commonly driven by blood sugar instability or thyroid excess. Early-morning awakening with inability to return to sleep is frequently driven by cortisol rhythm inversion or depression biology. Each pattern has a different mechanism and requires a different intervention.

Key distinction: Sleep disturbance encompasses the broad spectrum of disrupted sleep quality. Insomnia is the specific clinical condition defined by difficulty initiating or maintaining sleep despite adequate opportunity. The Lamkin Clinic evaluates insomnia through the metabolic, hormonal, and neurochemical lens that identifies why the brain cannot transition to or maintain sleep, rather than prescribing sedation to override the wakefulness signal.

Why Insomnia Matters

Health Consequences

  • Cardiovascular risk: chronic insomnia increases heart disease risk by 45 percent and stroke risk by 15 percent independent of other risk factors
  • Metabolic impact: even one week of sleep restriction produces measurable insulin resistance, increased appetite hormones (ghrelin), and reduced satiety signaling (leptin)
  • Cognitive decline: the glymphatic system clears amyloid-beta and metabolic waste during deep sleep. Chronic insomnia impairs this clearance, accelerating cognitive decline
  • Immune dysfunction: sleep deprivation reduces natural killer cell activity by up to 70 percent and increases inflammatory cytokine production

Why Standard Treatment Is Incomplete

  • Sedative-hypnotics suppress wakefulness but do not produce natural sleep: zolpidem and benzodiazepines alter sleep architecture, reducing the deep sleep and REM stages that provide the restorative benefits
  • No metabolic evaluation is performed: cortisol rhythm, blood sugar stability, thyroid function, magnesium status, and progesterone level are not assessed in standard insomnia treatment
  • Medication dependence develops: GABA-A receptor downregulation produces tolerance, requiring escalating doses and making discontinuation difficult
  • The mechanism producing the insomnia continues: the patient sleeps with medication while the cortisol dysregulation, blood sugar instability, or hormonal deficiency progresses untreated

Common Symptoms

Sleep-Onset Insomnia

  • Lying awake 30+ minutes despite being in bed on time
  • Racing mind that will not quiet
  • Physical tiredness with mental wakefulness
  • Anxiety or agitation as bedtime approaches

Sleep-Maintenance Insomnia

  • Waking at 2 to 4 AM with difficulty returning to sleep
  • Racing heart or sweating upon awakening (adrenaline surge)
  • Feeling hungry upon nocturnal awakening
  • Fragmented sleep with multiple awakenings

Daytime Consequences

  • Fatigue disproportionate to sleep duration
  • Brain fog and concentration difficulty
  • Irritability and mood instability
  • Reliance on caffeine to maintain daytime alertness

Root Causes: A Functional Medicine Perspective

Each insomnia pattern corresponds to a specific biological mechanism. Identifying the pattern guides the laboratory evaluation and determines the treatment.

Elevated Evening Cortisol (The Hyperarousal Pattern)

The most common functional medicine finding in sleep-onset insomnia. Cortisol must decline from its morning peak to its nadir around midnight for melatonin to rise and initiate sleep. Chronic stress and HPA axis dysregulation produce sustained evening cortisol that blocks this decline. The patient is physically exhausted but mentally wired. 4-point salivary cortisol testing identifies this pattern precisely. Treatment: phosphatidylserine (300mg at bedtime reduces cortisol), ashwagandha, and circadian anchoring through evening light restriction.

Nocturnal Hypoglycemia (The 2 to 4 AM Awakening Pattern)

During sleep, the brain relies on stable blood glucose for fuel. When blood sugar drops too low, the body mounts a counter-regulatory response with adrenaline and cortisol to raise glucose. This adrenaline surge produces the characteristic 2 to 4 AM awakening with racing heart, sweating, and difficulty returning to sleep. Insulin resistance and reactive hypoglycemia increase the risk of nocturnal blood sugar instability. Treatment: protein and fat at the evening meal or bedtime snack, insulin sensitization, and blood sugar stabilization.

GABA Deficiency and Magnesium Depletion

GABA is the brain's primary inhibitory neurotransmitter, responsible for downshifting neural activity from wakefulness to sleep. GABA receptor function requires magnesium as a cofactor. Magnesium deficiency produces GABA receptor underactivation, contributing to the inability to transition from alert wakefulness to relaxed drowsiness. This mechanism frequently coexists with the cortisol pattern and responds to magnesium glycinate (400mg at bedtime).

Progesterone Deficiency

Progesterone is a potent GABA-A receptor agonist with natural sedative properties. Perimenopausal and menopausal progesterone decline is a common and underrecognized driver of new-onset insomnia in women over 40. The insomnia onset frequently coincides with cycle changes or perimenopause. Bioidentical micronized progesterone (100 to 200mg at bedtime) restores the GABA-A agonist effect and simultaneously provides endometrial protection when used with estrogen replacement.

Thyroid Dysfunction and Circadian Disruption

Hyperthyroidism produces sympathetic activation that disrupts both sleep onset and maintenance. Even subclinical thyroid excess can impair sleep. Circadian rhythm disruption from evening screen exposure, irregular sleep timing, shift work, or jet lag desynchronizes the melatonin-cortisol rhythm. Without proper circadian anchoring, sleep onset becomes erratic regardless of fatigue level.

Conventional vs Functional Medicine Approach

DomainConventional MedicineFunctional Medicine
AssessmentSleep history, questionnaires; no metabolic evaluation4-point salivary cortisol, RBC magnesium, thyroid panel, fasting insulin, progesterone, melatonin
TreatmentSleep hygiene advice, cognitive behavioral therapy, sedative-hypnoticsMechanism-specific: cortisol restoration, blood sugar stabilization, magnesium repletion, progesterone support, circadian anchoring
MedicationZolpidem, trazodone, benzodiazepines (symptom suppression)Targeted supplements addressing the specific driver; medications only as short-term bridge
OutcomeMedication-dependent sleep; altered sleep architectureRestored natural sleep through biological correction; medication-free in most cases

Key Labs to Evaluate

How to Interpret These Labs Together

Elevated bedtime cortisol with low DHEA-S and sleep-onset insomnia confirms the HPA-driven hyperarousal pattern. The cortisol should be near zero at bedtime; elevation prevents melatonin release. Phosphatidylserine 300mg at bedtime, ashwagandha, evening light restriction, and stress reduction protocols normalize this pattern within 4 to 8 weeks.

Normal cortisol rhythm with low RBC magnesium and perimenopausal status identifies the dual-mechanism pattern: GABA receptor underactivation from magnesium depletion compounded by loss of progesterone's GABA-A agonist effect. Magnesium glycinate 400mg at bedtime plus micronized progesterone 100 to 200mg at bedtime addresses both mechanisms simultaneously.

Elevated fasting insulin with 2 to 4 AM awakenings and nocturnal sweating confirms the blood sugar instability pattern: nocturnal hypoglycemia triggering counter-regulatory adrenaline. Protein-fat bedtime snack for immediate relief, plus insulin sensitization through dietary modification and berberine for sustained correction.

Common Patterns Seen in Patients

  • The executive on zolpidem for 3 years who sleeps but wakes exhausted: Zolpidem produces pharmacological sedation but suppresses deep sleep stages where restoration occurs. 4-point cortisol shows elevated bedtime cortisol. RBC magnesium depleted. The medication was overriding a solvable problem. Cortisol normalization plus magnesium repletion produced natural sleep onset within 6 weeks. Zolpidem tapered and discontinued over 4 weeks.
  • The perimenopausal woman whose insomnia started with cycle changes: New-onset sleep-onset and sleep-maintenance insomnia beginning at age 46. Progesterone unmeasurably low. Prescribed trazodone. Micronized progesterone 200mg at bedtime restored sleep within the first week through GABA-A agonism, simultaneously providing endometrial protection. Trazodone discontinued.
  • The patient who wakes at 3 AM every night with a racing heart: Attributed to anxiety. Prescribed lorazepam. Fasting insulin 14, HbA1c 5.6, reactive hypoglycemia pattern on glucose tolerance. The 3 AM awakening was counter-regulatory adrenaline from nocturnal blood sugar crash, not anxiety. Protein-fat bedtime snack eliminated awakenings within days. Insulin sensitization for long-term resolution. Lorazepam discontinued.
  • The patient with insomnia, brain fog, fatigue, and anxiety who sees four specialists: Sleep medicine for insomnia (zolpidem), psychiatry for anxiety (SSRI), neurology for brain fog (no findings), and primary care for fatigue (no findings). 4-point cortisol shows elevated evening cortisol and blunted morning cortisol. One mechanism producing four symptoms treated by four specialists with four medications. HPA axis restoration resolved all four symptoms and enabled discontinuation of all four medications over 3 months.

Treatment and Optimization Strategy

Mechanism-Specific Insomnia Correction

Neurochemical and Hormonal

  • Magnesium glycinate 400mg at bedtime for GABA receptor support and muscle relaxation (foundation for all insomnia patients)
  • Phosphatidylserine 300mg at bedtime when elevated evening cortisol is confirmed on salivary testing
  • Ashwagandha (300 to 600mg KSM-66) for HPA axis modulation and cortisol rhythm normalization
  • Micronized progesterone 100 to 200mg at bedtime when progesterone deficiency is confirmed in perimenopausal or menopausal women

Metabolic and Circadian

  • Protein-fat evening meal or bedtime snack for blood sugar stability through the night (prevents nocturnal hypoglycemia)
  • Insulin sensitization when insulin resistance is driving blood sugar instability
  • Morning bright light exposure (10,000 lux, 20 to 30 minutes) to anchor circadian cortisol peak and downstream melatonin timing
  • Evening blue light elimination (2 hours before bed) to prevent melatonin suppression from screen-emitted light

What Most Doctors Miss

  • Cortisol rhythm is not evaluated: the most common functional driver of sleep-onset insomnia (elevated evening cortisol) is invisible without 4-point salivary cortisol testing, which is never ordered in standard insomnia evaluation.
  • Blood sugar instability is not connected to night awakenings: the 2 to 4 AM awakening pattern with racing heart is frequently diagnosed as anxiety when the actual mechanism is nocturnal hypoglycemia producing counter-regulatory adrenaline. Fasting insulin and dietary history identify this immediately.
  • Progesterone deficiency is not evaluated: new-onset insomnia in perimenopausal women frequently corresponds to progesterone decline. Progesterone's GABA-A agonist effect is potent and its loss is a direct, treatable cause of insomnia.
  • Sedative medications suppress natural sleep architecture: the deep sleep and REM stages that provide cognitive, metabolic, and immune restoration are reduced by sedative-hypnotics, producing sleep that is pharmacologically induced but not biologically restorative.

When to Seek Medical Care

If you experience insomnia lasting more than 4 weeks, insomnia that does not respond to sleep hygiene measures, night awakenings with racing heart or sweating, or new-onset insomnia coinciding with hormonal changes (perimenopause, cycle irregularity, stress), a comprehensive evaluation of the biological mechanisms driving the wakefulness is warranted. Sleep medication should not be the first or only intervention.

Recommended Testing

Insomnia evaluation identifies the specific metabolic, hormonal, and neurochemical mechanism preventing sleep onset or maintenance in each patient.

Cortisol and Neurochemical

  • Cortisol (4-point salivary)
  • DHEA-S
  • RBC Magnesium
  • Iron / Ferritin

Metabolic and Hormonal

  • Fasting Insulin / HOMA-IR
  • TSH, Free T3
  • Progesterone (women)
  • Vitamin D

Need metabolic and hormonal testing alongside cortisol?

Explore All Testing Options →

Frequently Asked Questions

What causes insomnia?

Insomnia has identifiable biological drivers: elevated evening cortisol, blood sugar instability causing nocturnal awakenings, thyroid dysfunction, GABA deficiency from magnesium depletion, progesterone deficiency in women, and circadian rhythm disruption. Each produces a distinct pattern that determines the treatment.

Can cortisol cause insomnia?

Yes. Cortisol must decline to its nadir around midnight for melatonin to rise and initiate sleep. Elevated evening cortisol from HPA axis dysregulation blocks this decline, producing the hyperarousal pattern of lying awake with a racing mind. 4-point salivary cortisol testing identifies this precisely.

Why do I wake up at 2 to 4 AM?

Early morning awakening is most commonly driven by nocturnal hypoglycemia. When blood sugar drops too low during sleep, the body releases adrenaline and cortisol to raise glucose. This adrenaline surge wakes you with a racing heart. Stabilizing evening blood sugar through protein and fat intake prevents this pattern.

Should I take sleeping pills?

Sedative-hypnotics suppress wakefulness but do not produce natural restorative sleep. They alter sleep architecture, produce dependence, and leave the biological mechanism untreated. They have a role in short-term bridge therapy while root causes are identified and corrected, but should not be the long-term strategy.

Can magnesium help with insomnia?

Yes. Magnesium is a cofactor for GABA receptor function. Magnesium glycinate (400mg at bedtime) supports the inhibitory neurotransmission needed for sleep onset with essentially no side effects. It is a foundation intervention for nearly all insomnia patients.

How The Lamkin Clinic Approaches Insomnia

Clinical Perspective
Insomnia is not a sleeping pill deficiency. Every patient who cannot sleep has a reason they cannot sleep, and that reason is identifiable. Is cortisol elevated at bedtime? Is blood sugar crashing at 3 AM? Is magnesium depleted? Has progesterone declined with perimenopause? When I find the mechanism and correct it, the brain does what it already knows how to do: it sleeps. The goal is not to force sleep with medication. The goal is to remove the biological obstacle preventing it.

Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma

At The Lamkin Clinic, insomnia is evaluated through comprehensive cortisol mapping, metabolic assessment, hormonal evaluation, and nutrient cofactor testing to identify the specific mechanism preventing natural sleep. Treatment targets the mechanism directly: cortisol rhythm restoration for hyperarousal, blood sugar stabilization for nocturnal awakenings, magnesium repletion for GABA support, progesterone for hormonal insomnia, and circadian anchoring for rhythm disruption. The goal is restored natural sleep without medication dependence.

Related Conditions

Related Symptoms

Insomnia has identifiable biological drivers. When the mechanism is corrected, the brain sleeps naturally.

The Lamkin Clinic evaluates insomnia through comprehensive cortisol mapping, metabolic assessment, and hormonal evaluation to identify and correct the specific driver preventing natural sleep. Schedule a consultation.

Schedule a Consultation

Medical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.

Hormone & Metabolic Health Hormone Replacement Therapy Diabetes & Insulin Resistance Medical Weight Loss Thyroid Optimization Men's Health Functional & Regenerative Medicine Functional & Regenerative Medicine Peptide Therapy Longevity & Healthspan Medicine Nutrition Services Conditions & Specialty Care Allergies & Immunology Biotoxin Illness & CIRS Cognitive Health Optimization Advanced Body Therapeutics Technology Center EXOMIND Emsculpt NEO Emsella Exion & EmFACE Natural Skin Rejuvenation Platelet Rich Plasma (PRP) Diagnostics & Testing Advanced Cardiovascular Screening DEXA Body Composition Scan Diagnostic Services Specialty Lab Services